| 2 Fat Dividends For A Lifetime Of Passive Income |
Berkshire Hathaway's portfolio of cash flow generators allows financial independence and opportunistic moves without financing dependencies. The "Income Method" aims to replicate Mr. Buffett's financial independence by prioritizing the generation of income streams from our personal portfolios. We discuss our top picks with yields of up to 15%. |
seekingalpha.com |
2025-05-14 11:35:00 |
Czytaj oryginał (ang.) |
| 8 Closed-End Fund Buys (And 2 Sells) In The Month Of March 2025 |
This month we got some increased market volatility, allowing me to put some of my cash pile to work in my closed-end fund portfolio. I also sold out of two positions, as they were starting to become on the more expensive side in terms of discounts/premiums. Adding to my positions regularly every month increases my cash flow annually, and even every month it grows. |
seekingalpha.com |
2025-04-14 19:01:28 |
Czytaj oryginał (ang.) |
| Bargain Alert: 2 Big Dividends, Up To 10% Yield |
Immunize your retirement from market noise with recurring dividends. We discuss two essential sectors for reliable income generation, regardless of economic conditions. Discover our top picks with up to 10% yields. |
seekingalpha.com |
2025-02-28 10:30:00 |
Czytaj oryginał (ang.) |
| I Am Loading Up Big Dividends For My Golden Years |
Innovation, demand, and shortage of providers have kept healthcare inflation significantly higher than the CPI. Regardless of the political scene, the aging U.S. population and rising chronic illnesses are undeniable truths to face. Income investing ensures consistent returns, allowing flexibility in financial planning, despite volatile stock prices. |
seekingalpha.com |
2025-02-17 09:35:00 |
Czytaj oryginał (ang.) |
| HQH: Improved Fundamentals, Strong Dividend Support |
HQH offers a high dividend yield of 13.6%, making it attractive for income-focused investors, despite potential tax consequences. The fund trades at a 7.86% discount to NAV, presenting a good entry point, especially with anticipated interest rate cuts and increased healthcare spending. HQH's portfolio is heavily concentrated in Biotechnology (64.6%), posing sector-specific risks but also benefiting from projected growth in biotech and healthcare spending. |
seekingalpha.com |
2025-02-09 19:18:03 |
Czytaj oryginał (ang.) |
| Aberdeen Or 'abrdn' - Either Way The Coverage Looks A Bit Thin |
Closed-end funds offer unique advantages, like buying at discounts and leveraging with institutionally priced debt, making them ideal income-generating vehicles. Cash distributions are key contributors to total return, but it is essential to be sure they are actually covered by fund earnings. Some investors overly prioritize distribution yields, neglecting the importance of considering total return as a whole. |
seekingalpha.com |
2025-01-17 13:10:47 |
Czytaj oryginał (ang.) |
| Don't Miss The Dividend Train, Yields Up To 15% |
For over 400 years, dividends have been a steady form of capital from the markets to your account. Dividends can generate dependable and powerful paychecks. We discuss two big yields from dependable sectors. |
seekingalpha.com |
2025-01-03 10:30:00 |
Czytaj oryginał (ang.) |
| HQH: Not For Income Investors |
I maintain a sell rating on the abrdn Healthcare Investors fund due to its incongruence with income investing and managed distribution plans. HQH has underperformed the Nasdaq Biotechnology Index and iShares Biotechnology ETF, highlighting its inability to generate alpha versus more tax-efficient alternatives. The fund's high yield is unsustainable, relying on capital gains and potentially forcing premature sales, which is unsuitable for income-oriented investors. |
seekingalpha.com |
2025-01-02 02:50:29 |
Czytaj oryginał (ang.) |
| My Top Retirement Strategy For 14% Dividends In 2025 |
Not many people know this, but if you really want to diversify—deftly balancing and rebalancing to maximize (and protect) your gains, you need to invest in closed-end funds (CEFs). |
forbes.com |
2024-12-24 15:38:00 |
Czytaj oryginał (ang.) |
| 11 Closed-End Fund Buys In The Month Of November 2024 |
This month, I've added to 11 different positions, but most of these were related to repurchases after the BlackRock tender offers. While I added to 11 different positions, these were all positions I had already held previously, so there were no new positions this month. In fact, I sold out of a fund to consolidate my holdings and reduce the number of funds held, as I did last month as well. |
seekingalpha.com |
2024-12-15 10:10:45 |
Czytaj oryginał (ang.) |
| 2 Cyber Monday Picks I Am Buying Hand Over Fist |
Buy income streams on sale, and collect your rewards for decades to come. I collect income from the market, not just cash from selling positions. Let the market fund your life; don't just dismantle your life savings. |
seekingalpha.com |
2024-11-30 12:30:00 |
Czytaj oryginał (ang.) |
| HQH: Declines Bring Potential Opportunity |
HQH has seen pressure recently due to regulatory uncertainty; while the closed-end funds discount has actually narrowed, it could be an interesting place to put some capital to work. The fund's 12% managed distribution policy has attracted interest from yield investors, though a quarterly pay may be less appealing. HQH's portfolio is tilted toward a heavier weight in biotech, with top holdings like Gilead Sciences showing resilience while others like Regeneron and Eli Lilly have struggled. |
seekingalpha.com |
2024-11-21 11:24:26 |
Czytaj oryginał (ang.) |
| Worried About A Recession? Income Solutions With Yields Up To 13% |
Time in the market trumps timing the market, but the timing of your retirement matters. In retirement, you need a portfolio capable of providing reliable income and mitigating sequence of return risk. We discuss two robust picks geared to provide steady income in retirement. |
seekingalpha.com |
2024-11-01 10:30:00 |
Czytaj oryginał (ang.) |
| HQH: High Yielding Exposure To Biotech With Positive Outlook |
abrdn Healthcare Investors operates as a closed end fund that aims to provide total returns comprised of high current income. HQH offers a high-yielding dividend rate of 12.7% and distributions are paid out on a monthly basis. The fund's focus on biotech holdings makes it vulnerable to interest rate changes but also positions it for potential growth with lower rates. |
seekingalpha.com |
2024-09-07 03:17:00 |
Czytaj oryginał (ang.) |
| Retire With Dividends: 2 Picks With Yields Up To 12% |
The prospects of a failed retirement are only heightened by a recession at the start of your retirement. Change the fuel behind your retirement finances with dividends vs. capital withdrawals. Unlock up to 12% yields with these income opportunities. |
seekingalpha.com |
2024-08-19 11:35:00 |
Czytaj oryginał (ang.) |
| abrdn U.S. Closed-End Funds Announce Distribution Payment Details |
PHILADELPHIA, PA / ACCESSWIRE / August 9, 2024 / The following abrdn U.S. Closed-End Funds (NYSE:ACP)(NYSE:ASGI)(NYSE:AWP)(NYSE:HQH)(NYSE:HQL)(NYSE:IFN)(NYSE:JEQ)(NYSE:THQ)(NYSE:THW)(NYSE American:FAX)(NYSE American:FCO)(NYSE American:IAF)(NYSE American:VFL), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on August 30, 2024 to all shareholders of record as of August 23, 2024 (ex-dividend date August 23, 2024). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF), the India Fund, Inc. (IFN) and the abrdn Japan Equity Fund, Inc. (JEQ) which will pay on September 30, 2024, to all shareholders of record as of August 23, 2024 (ex-dividend date August 23, 2024). |
accesswire.com |
2024-08-09 20:17:00 |
Czytaj oryginał (ang.) |
| HQH: Discount Remains Attractive With A Now Higher Distribution Rate |
The healthcare sector is traditionally defensive during economic downturns, but not all industries within the healthcare sector are created equal. abrdn Healthcare Investors Fund focuses on the more cyclical biotech space, with over half of its portfolio allocated there. HQH's managed distribution policy was increased significantly since our prior update, which was a factor in the funds discount narrowing, but it continues to trade at an attractive discount. |
seekingalpha.com |
2024-07-17 20:33:49 |
Czytaj oryginał (ang.) |
| HQH: Double-Digit Discount And Dividend Ready For Biotech Rally |
HQH features a deep NAV discount at 11%, it is cheap and offers good opportunity for price appreciation. Biotech sector is showing strength in recent market rally. HQH with high yield at 13% is a good buy for income investors to participate the promising biotech rally. Record financing activities in the sector fuel the business growth and set up for a sustainable market recovery. |
seekingalpha.com |
2024-07-17 10:56:36 |
Czytaj oryginał (ang.) |
| Make Money While You Sleep, 2 Big Dividends For A Retirement Dream |
What is your dream retirement? Make goals to achieve it. Don't make monetary number goals that can't answer the "what then?" question. I meet expenses head-on with highly valuable income. |
seekingalpha.com |
2024-07-13 11:35:00 |
Czytaj oryginał (ang.) |
| abrdn U.S. Closed-End Funds Announce Results of Annual Meeting of Shareholders |
PHILADELPHIA, PA / ACCESSWIRE / June 26, 2024 / The following abrdn U.S. Closed-End Funds (NYSE:HQH)(NYSE:THQ)(NYSE:THW) announced they each held their Annual Meeting of Shareholders (the "Meetings") on June 25, 2024. At the Meetings, shareholders of the respective Funds voted on the proposals set forth below: abrdn Healthcare Investors ("HQH") As of the record date, April 1, 2024, HQH had outstanding 50,624,847 shares of common stock. |
accesswire.com |
2024-06-26 22:08:00 |
Czytaj oryginał (ang.) |
| 2 Magnificent Funds To Generate Passive Income |
$7.1 trillion is invested in passive ETFs, rocking the market with their inflows and outflows. Few passive ETFs help you achieve specific goals. We look for options to meet our income needs for a lifetime. |
seekingalpha.com |
2024-06-10 11:35:00 |
Czytaj oryginał (ang.) |
| Private Advisor Group LLC Acquires 4,337 Shares of Abrdn Healthcare Investors (NYSE:HQH) |
Private Advisor Group LLC raised its holdings in Abrdn Healthcare Investors (NYSE:HQH – Free Report) by 16.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 31,510 shares of the financial services provider’s stock after purchasing an additional 4,337 shares during the quarter. Private Advisor Group LLC owned approximately 0.07% of Abrdn Healthcare Investors worth $522,000 as of its most recent SEC filing. A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Blue Bell Private Wealth Management LLC raised its holdings in shares of Abrdn Healthcare Investors by 76.6% in the fourth quarter. Blue Bell Private Wealth Management LLC now owns 10,420 shares of the financial services provider’s stock valued at $173,000 after buying an additional 4,520 shares during the last quarter. Milestone Asset Management LLC acquired a new stake in Abrdn Healthcare Investors in the 4th quarter valued at about $212,000. WNY Asset Management LLC acquired a new position in shares of Abrdn Healthcare Investors during the third quarter worth approximately $213,000. Capital Investment Advisory Services LLC lifted its position in shares of Abrdn Healthcare Investors by 6.6% during the fourth quarter. Capital Investment Advisory Services LLC now owns 16,238 shares of the financial services provider’s stock worth $269,000 after purchasing an additional 1,000 shares in the last quarter. Finally, Atomi Financial Group Inc. grew its stake in shares of Abrdn Healthcare Investors by 11.0% during the third quarter. Atomi Financial Group Inc. now owns 20,094 shares of the financial services provider’s stock valued at $312,000 after purchasing an additional 1,992 shares during the last quarter. Institutional investors and hedge funds own 32.60% of the company’s stock. Abrdn Healthcare Investors Stock Performance HQH stock opened at $17.42 on Monday. The company has a 50 day moving average price of $16.56 and a 200 day moving average price of $16.45. Abrdn Healthcare Investors has a fifty-two week low of $14.31 and a fifty-two week high of $17.68. Abrdn Healthcare Investors Increases Dividend The company also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Thursday, May 23rd will be given a dividend of $0.59 per share. The ex-dividend date is Wednesday, May 22nd. This represents a $2.36 dividend on an annualized basis and a dividend yield of 13.55%. This is an increase from Abrdn Healthcare Investors’s previous quarterly dividend of $0.48. About Abrdn Healthcare Investors (Free Report) Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. Read More Five stocks we like better than Abrdn Healthcare Investors Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours? MarketBeat Week in Review – 5/13 – 5/17 Low PE Growth Stocks: Unlocking Investment Opportunities Take-Two Interactive Software Offers 2nd Chance for Investors Investing in Commodities: What Are They? How to Invest in Them Deere & Company’s Q2 Report: Strong Revenue, Cautious Outlook Want to see what other hedge funds are holding HQH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Abrdn Healthcare Investors (NYSE:HQH – Free Report). |
https://www.defenseworld.net |
2024-05-20 09:08:50 |
Czytaj oryginał (ang.) |
| HQH: Future Rate Cuts Will Help Fund's Performance |
HQH: Future Rate Cuts Will Help Fund's Performance |
seekingalpha.com |
2024-05-11 08:55:02 |
Czytaj oryginał (ang.) |
| abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH) Announce an Additional 20% Increase in Distribution Rates Representing a 50% Increase Since January 2024 |
PHILADELPHIA, PA / ACCESSWIRE / May 9, 2024 / abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH), (collectively, the "Funds") each, a closed-end management investment company, announced today its Board of Trustees (each a "Board" and collectively, the "Boards") have approved an increase in each Fund's respective annualized distribution rate on NAV from 10% to 12%. Notably, HQH and HQL had previously announced distribution increases in February 2024, which increased the annualized distribution rate from 8% to 10%. |
accesswire.com |
2024-05-09 21:45:00 |
Czytaj oryginał (ang.) |
| Buy These 2 Picks If Nothing Else In May |
April showers are over, it is time to focus on our top picks for May. Enjoy the warmer weather, improve your health, and improve your portfolio's exposure to the healthcare sector. We look at two outstanding funds to unlock regular income from this sector. |
seekingalpha.com |
2024-05-08 11:35:00 |
Czytaj oryginał (ang.) |
| The 'Undercovered' Dozen From March 2024 |
Introducing a new recurring series to help you sift through ideas and data on the site: The "Undercovered" Dozen. In this monthly series, we'll cover twelve ideas from the previous month on stocks that receive limited coverage across Seeking Alpha. |
seekingalpha.com |
2024-04-12 18:30:00 |
Czytaj oryginał (ang.) |